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Abstract
In Korea, chestnut production is increasing each year, but consumption is far below production. We investigated the effect of chestnut extracts 
on antioxidant activity and anticancer effects. Ethanol extracts of raw chestnut (RCE) or chestnut powder (CPE) had dose-dependent superoxide
scavenging activity. Viable numbers of MDA-MD-231 human breast cancer cells, DU145 human prostate cancer cells, and AGS human gastric 
cancer cells decreased by 18, 31, and 69%, respectively, following treatment with 200 μg/mL CPE for 24 hr. CPE at various concentrations (0-200
µg/mL) markedly decreased AGS cell viability and increased apoptotic cell death dose and time dependently. CPE increased the levels of cleaved
caspase-8, -7, -3, and poly (ADP-ribose) polymerase in a dose-dependent manner but not cleaved caspase-9. CPE exerted no effects on Bcl-2 and 
Bax levels. The level of X-linked inhibitor of apoptosis protein decreased within a narrow range following CPE treatment. The levels of Trail,
DR4, and Fas-L increased dose-dependently in CPE-treated AGS cells. These results show that CPE decreases growth and induces apoptosis in
AGS gastric cancer cells and that activation of the death receptor pathway contributes to CPE-induced apoptosis in AGS cells. In conclusion, CPE 
had more of an effect on gastric cancer cells than breast or prostate cancer cells, suggesting that chestnuts would have a positive effect against
gastric cancer. 
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Introduction1)
The chestnut belongs to the genus Castanea in the Fagaceae 
family and is native to temperate regions in Asia, Europe, North 
America, and North Africa. There are 13 species, and the Japanese, 
Korean (Castanea crenata Sieb et Zucc.), Chinese (Castanea 
mollissima Blume), European (Castanea sativa Mill), and 
American (Castanea dentate Borkhausen) chestnuts are mainly 
cultivated for fruit [1].
Currently, chestnut trees are cultivated on approximately 
80,000 ha in Korea, yielding 94,000 tons, and most are produced 
in Gongju, (10,246 tons of chestnut in 4,515 ha of farmland) 
[2]. Chestnut trees have been cultivated throughout history, as 
they are used in traditional Korean ceremonies. Chestnuts are 
also consumed as a favorite food because of their good nutrition. 
However, to increase chestnut consumption, it is necessary to 
demonstrate that chestnuts are healthy. 
According to oriental medicine, chestnuts cure stomach cancer, 
epistaxis, and hemafecia, but the components and their functions 
that cure diseases have not been systematically tested [3]. The 
antioxidant activity of the chestnut inner shell, leaves, and 
flowers has been tested [4,5]. Because the flesh and inner shell 
of chestnuts have antioxidant activity, we investigated whether 
uncooked chestnuts and processed chestnut powder extracts also 
have antioxidant effects. The objective of this study was to test 
the activity of chestnut extracts against cancer cell proliferation 
and to examine the molecular mechanisms underlying this 
phenomenon as a trial for developing a novel functional 
anticancer food. Thus, we investigated the effect of chestnuts 
on cell proliferation and apoptosis using MDA-MD-231 human 
breast cancer cells, DU145 human prostate cancer cells, and AGS 
human gastric cancer cells.
Materials and Methods
Materials
Raw chestnuts and chestnut powder were produced in Gongju, 
Korea. According to Gongju City, chestnut powder is obtained 
after the flesh and shell, including the outer and inner parts, are 
ground and mixed with water. This powder sells in the market 
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under the name chestnut starch. The reagents employed in this 
study were purchased from the indicated suppliers: Anti-β-actin 
antibody and 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium 
bromide (MTT) were obtained from Sigma-Aldrich Co. (St. 
Louis, MO, USA); Dulbecco’s Modified Eagle’s Medium/Ham’s 
F-12 nutrient mixture (DMEM/F-12) was purchased from Gibco 
BRL (Gaithersburg, MD, USA); fetal bovine serum (FBS) was 
obtained from Cambrex Bio Technology (Walkersville, MD, 
USA); horse-radish peroxidase (HRP)-conjugated anti-rabbit and 
anti-mouse IgG were purchased from Amersham Biosciences 
(Arlington Heights, IL, USA); antibodies against cleaved caspase-3, 
cleaved caspase-7, cleaved caspase-9, cleaved poly (ADP-ribose) 
polymerase (PARP), caspase-8, Bid, and X-linked inhibitor of 
apoptosis protein (XIAP) were obtained from Cell Signaling 
Technology (Beverly, MA, USA); antibody against tumor necrosis 
factor-related apoptosis including ligand (TRAIL) was obtained 
from BD Pharmingen (Franklin Lake, NJ, USA); antibodies 
against Fas, Fas ligand (Fas-L), Bcl-2, and Bax were purchased 
from Santa Cruz Biotechnology (Santa Cruz, CA, USA); and 
antibodies against death receptor (DR) 4 and 5 were obtained 
from Imgenex (San Diego, CA, USA). All other materials were 
obtained from Sigma-Aldrich Co.
Extract preparation 
Preparation of aqueous extracts. Chestnut powder (0.5 kg) was 
extracted with water for 30 min using a sonication method. The 
extract was centrifuged at 6,000 rpm for 20 min to remove the 
residue. This procedure was repeated twice more with a sonication 
time of 30 min. The upper phase was collected and lyophilized 
(CPW). The CPW yield was 5.05 g (0.61%). Pulverized raw 
chestnut (1.5 kg) was extracted with water by refluxing at 100°C 
for 3 hr. The extract was centrifuged at 6,000 rpm for 20 min 
to the separate residue. The upper phase was divided into a 
non-mucous (RCW1) and mucous (RCW2) fractions. Each 
fraction was lyophilized, and the yields were 78.92 g (5.35%) 
and 60.57 g (4.4%), respectively.
Preparation of ethanol extracts.  Pulverized raw chestnut or 
chestnut powder (1.5 kg each) was subjected to three extractions 
with 95% ethanol (4.5 L) for 3 h and then filtered (Advantec 
filter paper, type 2; Advantec, Tokyo, Japan). Each combined 
filtrate was then concentrated in vacuo at 45°C (Bchi Rotavapor 
R-220, Flawil, Switzerland). The yields of the pulverized raw 
chestnut extract (RCE) and chestnut powder extract (CPE) were 
68.30 g (4.55%) and 1.89 g (0.13%), respectively.
Antioxidant activity 
Photochemiluminescence was used to determine the antioxidant 
activity of the extracts. We used an antioxidant capacity of water 
extracts (ACW) kit (Analytik Jena AG Co., Jena Germany) for 
the water soluble extracts and an antioxidant capacity of lipid 
extracts (ACL) kit for the water insoluble extracts (Analytik 
Jena), in which luminal plays a double role as a photosensitizer 
and an oxygen radical detection reagent, according to the 
manufacturer's instructions. Results were calculated in ascorbate 
equivalents for ACW and trolox equivalents for ACL. 
Cell culture and cell viability assay
MDA-MB-231 human breast cancer cells, DU145 human 
prostate cancer cells, and AGS human gastric cancer cells were 
obtained from the American Type Culture Collection (Manassas, 
VA, USA). All cells were maintained in DMEM/F12 containing 
100 mL/L FBS with 100,000 U/L penicillin and 100,000 mg/L 
streptomycin at 37°C in 5% CO2. We plated cells in 24-well 
plates with DMEM/F-12 containing 100 mL/L FBS for 24 h to 
examine the effect of the extracts on cell growth. Prior to extract 
treatment, the cell monolayers were rinsed and serum-deprived 
for 24 h with DMEM/F-12 containing 10 mL/L FBS (serum- 
deprivation medium). After serum-deprivation, we replaced the 
serum-deprivation medium with or without the indicated 
concentrations of extracts. Viable cell numbers were estimated 
by the MTT assay, as described previously [6,7]. 
Quantitative analysis of apoptotic cells
AGS cells were plated in 24-well plates and treated with 
various concentration of CPE for 24, 48, or 72 hr. The cells 
were assayed to quantitatively determine the mono- and oligo- 
nucleosomes released into the cytoplasm using a Cell Death 
Detection ELISA
PLUS kit (Roche, Mannheim, Germany), according 
to the manufacturer's instruction.
Western blot analysis
The cells were cultured in 100 mm dishes and treated with 
CPE using the method described above. Total cell lysates were 
prepared as previously described [8]. We determined protein 
content in total cell lysates using the BCA Protein Assay kit 
(Pierce, Rockford, IL, USA). The proteins in the total cell lysates 
were resolved on a sodium dodecyl sulfate (SDS) 4-20% or 
10-20% polyacrylamide gels and transferred to a polyvinylidene 
fluoride membrane (Millipore, Bedford, MA, USA). Western blot 
analyses were performed as previously described [7]. We 
detected the signals based upon the enhanced chemiluminescence 
method using the Immobilon
TM Western Chemiluminescent HRP 
Substrate (Millipore). The abundance of each band was quantified 
using the Bio-profile Bio-1D application (Vilber-Lourmat, 
Marine la Vallee, France), and expression levels were normalized 
to  β-actin. 
Statistical analysis
The results are expressed as means ± SEMs, and were analyzed 
by an analysis of variance. Differences among treatment groups Hyun Sook Lee et al. 187
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Fig. 1. Effect of chestnut extracts on the viable cell numbers of MDA-MD-231, DU145, and AGS cells. (A) MDA-MB-231, (B) DU145, and (C) AGS cells were plated 
at a density of 50,000 cells/well in 24-well plates with DMEM/F12 supplemented with 10% FBS. One day after plating, the monolayers were serum-deprived with DMEM/F12 
supplemented with 1% FBS serum-deprivation medium for 24 h. After serum deprivation, the cells were incubated in serum-deprivation medium in the absence or presence 
of 200 μg/mL viscous, aqueous extract of raw chestnut (RCW1), non-viscous, aqueous extract of raw chestnut (RCW2), aqueous extract of chestnut powder (CPW), ethanol
extract of raw chestnut (RCE), or an ethanol extract of chestnut powder (CPE) for 24 hr. Cell numbers were estimated by the MTT assay. Each bar represents the mean
± SEM  (n = 6).  Means  at  a  time  without  a  common  letter  differ  significantly,  P < 0.05.
Extracts Concentration
(μg/mL)
Ascorbic acid equivalent
(nM)
Trolox equivalent
(nM)
RCW1
1.97 1.86
0.39 0.15
RCW2
1.97 1.5
0.39 0.25
CPW
1.97 0
0.39 0.19
RCE
0.39 2.22
0.20 1.91
0.04 1.33
CPE
0.39 2.88
0.20 1.91
0.04 1.36
RCW1; viscous,  aqueous  extract of raw  chestnut, RCW2,  non-viscous,  aqueous 
extract of raw chestnut; CPW, aqueous extract of chestnut powder; RCE, ethanol 
extract  of  raw  chestnut;  CPE,  ethanol  extract  of  chestnut  powder
Table 1. Effect of various extracts on superoxide radical scavenging effects were analyzed by Duncan's multiple-range tests utilizing the SAS 
system for Windows V 9.1 (SAS Institute, Cary, NC, USA). 
Results
The chestnut ethanol extract had antioxidant activity
We performed preliminary studies to determine the antioxidant 
activity of the chestnut extracts. The superoxide radical scavenging 
effect of water soluble extracts (such as RCW1, RCW2, and 
CPW) or ethanol extracts (such as RCE and CPE) were compared 
to ascorbate or trolox, respectively. The RCE and CPE revealed 
dose dependent superoxide scavenging activity (Table 1).188 Chestnut extract induces apoptosis in cancer cells
 (A)
 (B)
Fig. 2. Effect of an ethanol extract of chestnut powder (CPE) on AGS cell 
viability and apoptosis. AGS cells were plated at a density of 50,000 cells/well in 
24-well plates with DMEM/F12 supplemented with 10% FBS. One day after plating, 
the monolayers were serum-deprived with DMEM/F12 supplemented with 1% FBS 
serum-deprivation medium for 24 h. After serum deprivation, cells were incubated 
in serum-deprivation medium in the absence or presence of various concentrations 
o f  C P E .  ( A )  C e ll  n u m b e r s  w e r e  e s t im a t e d  b y  t h e  M T T  a s s a y .  ( B )  A poptotic  cells 
were  detected  with  the  Cell  death  detection  ELISA
PLUS.  Each  bar  represents  the 
mean ± SEM (n = 6). Means without a common letter differ significantly, P < 0.05.
  (A)
  (B)
Fig. 3. Effect of an ethanol extract of chestnut powder (CPE) on the levels of 
cleaved caspases (A) and poly (ADP-ribose) polymerase (PARP) (B) in AGS 
cells. Cells were plated and treated with various concentrations of CPE for 48 h 
as  described  in  Fig.  2.  Total  cell  lysates  were  analyzed  by  Western  blotting  with 
the indicated antibodies. Photographs of chemiluminescent detection of the blots, 
which are representative of three independent experiments, are shown. The relative 
abundance  of  each  band  to  their  own  β-actin  concentration  was  quantified  and 
control levels were set to 1. The adjusted mean ± SEM is shown above each blot. 
Means  without  a  common  letter  differ  significantly,  P < 0.05.
Chestnut ethanol extracts inhibited growth and induced apoptosis 
in AGS cells
We determined whether the chestnut extracts moderated growth 
of MDA-MD-231, DU145, and AGS cells. In MDA-MB-231 
cells, the water soluble chestnut extracts (RCW1, RCW2, CPW) 
and CPE induced a mild decrease in viable cell numbers within 
24 hr after adding 200 μg/mL of extract (Fig. 1A). In DU145 
cells, the water soluble extracts such as RCW1, RCW2, and CPW 
and the ethanol extract of raw chestnut, RCE, exerted no effects 
on cell growth. However a 24 hr treatment of DU145 cells with 
200  μg /mL CPE resulted in a 30.5% decrease in viable cell 
numbers (Fig. 1B). In AGS cells, the water soluble extracts 
significantly increased cell growth. RCE exerted no effect on 
AGS cell growth as in the other cancer cell lines. However, a 
24 hr treatment of AGS cells with 200 μg/mL CPE resulted in 
a 69.4% decrease in viable cell numbers (Fig. 1C). 
We found that CPE had the greatest cancer cell growth 
inhibiting effect, among the various chestnut extracts and that 
AGS cells were most affected by CPE among the various cancer 
cell lines. AGS cells were treated with various CPE concentrations 
(0, 25, 50, 75, 100, 200 μg/mL) to determine whether CPE 
inhibits stomach cancer cell growth. As a result, CPE markedly 
decreased AGS cell viability dose-dependently and time-dependently 
(Fig. 2A). To determine if the decrease in cell growth observed 
after CPE treatment was due to the induction of apoptosis, AGS 
cells were treated for 24, 48, or 72 hr with various CPE 
concentrations (0, 50, 100, or 200  μg/mL) and the degree of 
apoptosis was estimated using an ELISA. CPE treatment induced 
an increase in the numbers of apoptotic AGS cells in a dose- 
dependent manner (Fig. 2B). 
The chestnut ethanol extract increased caspase activation and 
enhanced PARP cleavage in AGS cells
Because CPE induced apoptosis in AGS cells, we assessed the 
effects of CPE on the activation of caspases and PARP cleavage. 
AGS cells were treated for 48 hr with various concentrations 
of CPE, and total cell lysates were prepared for Western blotting 
with antibodies that detect the cleaved forms of the enzymes. 
CPE increased the protein levels of cleaved caspase-8, -7, and 
-3 in a dose-dependent manner. The level of cleaved caspage-9 Hyun Sook Lee et al. 189
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Fig. 4. Effect of an ethanol extract of chestnut powder (CPE) on the levels of 
Bcl-2, Bax, and an inhibitor of apoptosis proteins (XIAP) in AGS cells. Cells 
were plated and treated with various concentrations of CPE for 48 h as described 
in  Fig. 2.  Total cell lysates were  analyzed by  Western blotting  with  the  indicated 
antibodies.  Photographs  of  chemiluminescent  detection  of  the  blo t s ,  w h i c h  a r e  
representative of three independent experiments, are shown. The relative abundance
of each band to their own β-actin concentration was quantified, and the control 
levels were set to 1. The adjusted mean ± SEM is shown above each blot. Means 
without  a  common  letter  differ  significantly,  P < 0.05.
Fig. 5. Effect of an ethanol extract of chestnut powder (CPE) on the levels of 
tumor necrosis factor-related apoptosis including ligand (TRAIL), DR4, Fas, and 
Fas-L in AGS cells. Cells were plated and treated with various concentrations of 
CPE for 48 h as described in Fig. 2. Total cell lysates were analyzed by Western 
blotting with the indicated antibodies. Photographs of chemiluminescent detection 
of the blots, which are representative of three independent experiments, are shown. 
The  relative  abundance  of  each  band  to  their  own  β-actin  concentration  was 
quantified, and the control levels were set to 1. The adjusted mean ± SEM is shown 
above  each  blot.  Means  without  a  common  letter  differ  significantly,  P < 0.05.
was not altered following CPE treatment (Fig. 3A). Additionally, 
CPE increased the PARP cleavage product in a concentration- 
dependent manner (Fig. 3B).
The chestnut ethanol extract did not affect the levels of Bcl-2 
family proteins but decreased the levels of XIAP in AGS cells
We then assessed the effects of CPE on the levels of Bcl-2, 
an antiapoptotic Bcl-2 family protein and Bax, a pro-apoptotic 
Bcl-2 family protein. CPE exerted no effects on the levels of 
Bcl-2 and Bax. (Fig. 4A). 
XIAP is an inhibitor of apoptotic proteins (IAP) and inhibits 
apoptosis by inhibiting caspase activity. We determined whether 
CPE decreased XIAP protein levels and found that the XIAP 
protein levels decreased slightly with CPE treatment (Fig. 4B). 
The chestnut ethanol extract increased the levels of TRAIL, DR4, 
and Fas-L in AGS cells
CPE had no effect on caspase-9 activity (Fig. 3A) or Bcl-2 
and Bax expression (Fig. 4A). However, CPE effectively increased 
caspase-8 activity (Fig. 3A). These results imply that CPE 
induced apoptosis by a death receptor mediated pathway. To 
confirm these results, we determined whether CPE increased the 
levels of TRAIL, DR4, Fas, and Fas-L proteins using Western 
blotting of total cell lysates. As a result, the levels of TRAIL, 
DR4, and Fas-L dose-dependently increased in CPE treated cells, 
but CPE did not affect the Fas level (Fig. 5).
Discussion
Oriental medicine and folk remedies have found that chestnuts 
promote digestion and strengthen the stomach. The dictionary 
of traditional Chinese medicine states that “Chestnut remedies 
gastric cancer, nosebleeds, and bloody excrement”. The Donguibogam 
states that chestnuts “fortify oneself, strengthen the stomach, 
reinforce vigor, and can be used as food”. Furthermore, the starch 
in chestnuts is an easily-digested, high quality sugar that contains 
gastric function enzymes, and a folk remedy suggests that 
chewing roasted chestnuts helps reduce stomach aches and 
diarrhea [4]. In the current study, we attempted to determine 
whether chestnut extracts have healthy functions. First, we 
detected the superoxide radical scavenging effects of aqueous 
and ethanol extracts from raw chestnuts and chestnut powder. 
As a result, we found that the ethanol extract increased antioxidant 
activity in a dose dependent manner. Several studies have 
indicated the antioxidant activities of chestnut bark, flower, leaf, 
and fruit extracts [5,6]. We investigated the effect of CPE on 
cell proliferation in several cell lines to determine whether this 
antioxidant effect could be extended to an anticancer effect, and 
CPE restrained cancer cell proliferation. In particular, CPE 
strongly retarded cell proliferation and promoted apoptosis in the 
AGS gastric cancer cell line.
Cancer development and progression is a very complex process. 
Cancer chemoprevention has gained more attention, presumably 
because it involves the use of dietary bioactive compounds to 190 Chestnut extract induces apoptosis in cancer cells
prevent, inhibit, or reverse the development of cancer [9]. 
Previous investigations have shown that cancer cell proliferation 
decreases by about 40% after injecting L1210 cells into the 
peritoneal cavity of mice and transplanting cancer cells [10]. In 
the present study, CPE had an antioxidant effect and promoted 
apoptosis in cancer cells, particularly in gastric cancer cells, and 
this result supports the folk remedies.
We studied the mechanism of apoptosis in CPE (0-200 μg/mL), 
which had the most antioxidant and anti-proliferation activity in 
AGS cells. Apoptosis occurs through an intrinsic pathway (also 
known as the mitochondrial pathway) and an extrinsic pathway 
(also known as the death receptor pathway) [11]. Apoptosis is 
initiated through the mitochondrial pathway following physiological 
conditions, such as oxidative stress, mitochondrial disturbance, 
and DNA damage. This pathway is involved in the permeabiliza-
tion of the outer mitochondrial membrane, which facilitates 
cytochrome c release into the cytoplasm. Cytochrome c binds 
the caspase adaptor apoptotic protease-activating factor-1 (Apaf-1), 
thereby triggering the apoptotic cascade by activating procaspase 
9 and forming an apoptosome complex. This apoptosome, in turn, 
activates the downstream effector caspases-3, -6, and -7, leading 
to apoptosis [12,13]. The typical executioners of apoptosis are 
proteolytic enzymes called caspases. Our results clearly demonstrate 
that CPE increased the activation of caspase-8, 7, and 3 and 
induced PARP cleavage. Caspase activation may be one of the 
major mechanisms by which CPE induced apoptosis.
Another important key player in the mitochondrial pathway 
of apoptosis is the Bcl-2 family, which consists of pro-apoptotic 
proteins and anti-apoptotic proteins. Bax, a pro-apoptotic member 
of the Bcl-2 family, induces the release of cytochrome c from 
mitochondria, thereby activating caspase-9. Bax promotes apoptosis 
by stimulating the release of the Smac/DIABLO protein from 
mitochondria, thereby inactivating IAPs, such as XIAP, cIAP1, 
cIAP2, and survivin [14]. However, Bcl-2 is an anti-apoptotic 
member of the Bcl-2 family that binds and inactivates Apaf-1. 
In the present study, we observed that CPE did not alter the 
levels of Bcl-2 and Bax. Moreover, the caspase-9 levels were 
not affected by CPE treatment. These results suggest that Bcl-2 
family is not the main cause of the apoptotic effect of CPE.
The extrinsic pathway of apoptosis is induced by ligand binding 
death receptors. The most important ligand-death receptor system 
includes tumor necrosis factor (TNF)-TNF receptor-1, Fas-L-Fas 
(also called CD95 or Apo1) and TRAIL-TRAIL receptor (including 
TRAIL-R1, also called DR4 and TRAIL-R2 or DR5). Binding 
of their receptors by the respective ligands leads to receptor 
oligomerization and recruitment of death signal adaptor proteins. 
For example, binding of Fas-L to Fas leads to recruitment of 
Fas-associated death domain (FADD) [15]. The oligomerized 
receptors and FADD form a death-inducing signaling complex, 
which binds to initiator caspases (caspase 8 and 10), thereby 
triggering the caspase cascade such as activation of caspase 3, 
which leads to apoptotic events. Fas and Fas-L are constitutively 
expressed in the gastrointestinal tract [16] and in gastric [17,18] 
and colon cancers [19]. Thus, the Fas/Fas-L system is an 
important target for apoptosis induction in gastric and colon 
cancers. Importantly, TRAIL preferentially induces apoptosis in 
cancer cells while exhibiting little or no toxicity in normal cells 
[20]. The TRAIL receptors, DR4 and DR5, are highly expressed 
in many cancers including gastric and colorectal cancers [14,20].
Initiator caspases, caspase-8 and -9, are activated by other 
pathways. Caspse-8 is activated by a combined cell death 
receptor, such as Fas, with a cell death receptor ligand in the 
external pathway, whereas caspase-9 is activated by the release 
of cytochrome c from the mitochondrial membrane, which 
activates the internal pathway [21-23]. In this study, CPE had 
no effect on caspase-9 activity (Fig. 3A) or Bcl-2 and Bax 
expression (Fig. 4). As shown in Fig. 3A, CPE effectively 
increased caspase-8 activity. These results suggest that CPE 
induced apoptosis by the death receptor mediated pathway. To 
confirm these results, we determined whether CPE increased the 
levels of death receptors using Western blotting of total cell 
lysates. As a result, Fas-L, DR4, and Trail levels were dose- 
dependently increased in the CPE-treated cells, indicating that 
activation of the death receptor pathway contributed to CPE- 
induced apoptosis in AGS cells. Further studies will be required 
to delineate the mechanisms by which CPE induced caspase-8 
activation in AGS cells. 
IAPs are a group of important apoptosis regulatory proteins. 
XIAP directly binds and inhibits key effector caspases, such as 
caspase 3, 7, and 9, thereby inhibiting apoptosis [24]. Downregulation 
of XIAP sensitizes gastric cancer cells to Trail and chemo-
therapeutic drug-induced apoptosis [25,26]. In the present study, 
the levels of XIAP decreased slightly with CPE treatment (Fig. 4). 
In conclusion, considering that CPE had more of an effect on 
gastric cancer cells than breast cancer or prostate cancer cells 
in this study, chestnuts may function more effectively to aid in 
the treatment of gastric cancer. We demonstrated that CPE 
decreased growth and induced apoptosis in AGS gastric cancer 
cells, which was mediated by caspase activation. Our results 
indicate that CPE activates caspases mainly through the extrinsic 
pathway. Further studies should explore the anticancer effect of 
chestnuts and the mechanism through in vivo studies and 
investigate the active ingredients in chestnut extracts that have 
an anticancer effect. 
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